sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 51-75 out of 1396.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>

Public Release: 29-Aug-2017
ESC Congress 2017
Meta-analysis suggests PCSK9 inhibitors do not increase short-term risk of type 2 diabetes
PCSK9 inhibitors do not increase short-term risk of type 2 diabetes, suggests a meta-analysis in more than 68,000 patients presented at ESC Congress today.
State University of Campinas

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2017
ESC Congress 2017
Dark chocolate with olive oil associated with improved cardiovascular risk profile
Dark chocolate enriched with extra virgin olive oil is associated with an improved cardiovascular risk profile, according to research presented today at ESC Congress.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2017
ESC Congress 2017
Poor sleep is associated with ischemic heart disease and stroke
Poor sleep is associated with ischemic heart disease and stroke, according to research presented today at ESC Congress. The observational study in nearly 13,000 people revealed different patterns of sleep disturbance between the two conditions, with ischemic heart disease being linked to shorter sleep and brief moments of waking up.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
Nature Microbiology
Drug breakthrough for mosquito virus outbreaks
Scientists have discovered a way that could help treat severe inflammation from an infectious mosquito-borne disease during outbreaks.

Contact: Stephanie Bedo
s.bedo@griffith.edu.au
61-408-727-734
Griffith University

Public Release: 28-Aug-2017
ESC Congress 2017
Atrial fibrillation and blood pressure: More than just a number (AFFIRM)
New research presented at ESC Congress today shows, for the first time, that blood pressure control is pivotal in reducing major bleeding and stroke risk in patients with atrial fibrillation (AF).
NIH/National Heart, Lung, and Blood Institute

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Anti-aldosterones save lives in STEMI heart attack patients: ALBATROSS, REMINDER
Certain heart attack patients who have ST-segment elevation myocardial infarction (STEMI) are significantly more likely to survive if they are treated immediately with anti-aldosterone-type drugs in addition to standard therapy, according to new research presented at ESC Congress today.
Assistance Publique-Hôpitaux de Paris (AP-HP), French Ministry of Health, Foundation of the Institute of Cardiometabolism And Nutrition (ICAN)

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
NIPPON follow-up: Shorter dual antiplatelet therapy stands the test of time (DAPT)
Three year follow-up of patients who received dual antiplatelet therapy (DAPT) after placement of a drug-eluting stent (DES) shows that a short course of the therapy continues to be as beneficial as a longer course.
Association for Establishment of Evidence in Interventions

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Lancet
New analysis examines how low cholesterol can safely go (FOURIER)
Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with progressively fewer cardiovascular events and appears to pose no safety concerns in patients with stable atherosclerotic cardiovascular disease over 2.2 years of follow-up, according to a new analysis of the FOURIER trial.
Amgen

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
PATHWAY-2 uncovers main cause of drug-resistant hypertension, finds old drugs work best
Salt retention is the main culprit behind drug-resistant hypertension (RHTN), with older diuretic medications being the most effective treatment, according to new results from the PATHWAY-2 study.
British Heart Foundation, National Institute for Health Research (NIHR)

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
SPRINT post-hoc analysis: Food for thought on defining the ideal blood pressure target
Adding to the debate on optimal blood pressure control, new findings presented at ESC Congress today suggest there may be variations in the ideal target depending on baseline pressure and overall cardiovascular risk.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Bag-mask ventilation fails to improve on endotracheal intubation in cardiac arrest (CAAM)
Bag-mask ventilation fails to improve on endotracheal intubation in out-of-hospital cardiac arrest patients, according to late-breaking results from the CAAM trial presented today in a Hot Line LBCT Session at ESC Congress.
2013 Hospital Programme for Clinical Research of the French Ministry of Health and by the Research Delegation of the Assistance Publique - Hopitaux de Paris

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Closure of left atrial appendage during heart surgery protects the brain (LAACS)
Closure of the left atrial appendage during heart surgery protects the brain, according to late-breaking research presented today in a Hot Line LBCT Session at ESC Congress.1 The results suggest that closure should be routinely added to open heart surgery.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
JAMA
Study reveals clinical benefit of LDL cholesterol lowering depends on how it is lowered
The benefit of lowering low-density lipoprotein (LDL) cholesterol depends on how it is lowered, according to late-breaking results from a naturally randomised genetic trial presented today in a Hot Line -- LBCT Session at ESC Congress1 and published in JAMA.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Sildenafil should be avoided in valve disease with residual pulmonary hypertension
Sildenafil should not be used to treat residual hypertension in patients with valvular heart disease, according to late-breaking results from the SIOVAC trial presented today in a Hot Line LBCT Session at ESC Congress. The off-label use of the drug led to worse clinical outcomes including a doubled risk of hospitalization compared to placebo.
Spanish Ministries of Health and Economy

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
European Heart Journal
Ibuprofen associated with blood pressure rise in arthritis patients at cardiovascular risk
Ibuprofen is associated with increased blood pressure and hypertension compared to celecoxib in patients with osteoarthritis or rheumatoid arthritis and increased risk of cardiovascular disease, according to late-breaking results from the PRECISION-ABPM study presented today in a Hot Line Session at ESC Congress and published in EHJ.
Pfizer

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
New England Journal of Medicine
Oxygen therapy does not improve survival (DETO2X-AMI)
Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late-breaking research presented today in a Hot Line LBCT Session at ESC Congress and published in the NEJM.
Swedish Heart-Lung Foundation, Swedish Research Council, Swedish Foundation for Strategic Research

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Apixaban lowers stroke risk in AF patients undergoing cardioversion (EMANATE)
Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with atrial fibrillation scheduled for elective cardioversion, according to late-breaking results from the EMANATE trial presented today in a Hot Line LBCT Session at ESC Congress. Rates of bleeding were similar between the two groups.
Pfizer, Bristol-Myers Squibb

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Lancet
Education and feedback improve use of stroke prevention drugs in AF (IMPACT-AF)
Education of healthcare providers and patients with atrial fibrillation has led to a 9 percent absolute increase in the use of anticoagulation therapies to reduce stroke, according to late-breaking results from the IMPACT-AF trial presented today in a Hot Line LBCT Session at ESC Congress1 and published in the Lancet.
Boehringer Ingelheim Pharmaceuticals Inc., Daiichi Sankyo, Bayer Pharmaceuticals, Bristol-Myers Squibb, Pfizer Inc.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Inclisiran lowers 'bad' cholesterol for up to 1 year (ORION 1)
Inclisiran lowers low-density lipoprotein (LDL; 'bad') cholesterol for up to one year in patients with high cardiovascular risk and elevated LDL cholesterol, according to late-breaking results from the ORION 1 trial presented today in a Hot Line LBCT Session at ESC Congress.
The Medicines Company

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
The Lancet
Renal denervation lowers blood pressure in hypertensive patients
Renal denervation lowers blood pressure in hypertensive patients not taking medication, according to late-breaking results from the SPYRAL HTN-OFF MED study presented today in a Hot Line LBCT Session at ESC Congress and published in the Lancet.
Medtronic

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Lancet
Screening for vascular disease saves one life for every 169 patients assessed (VIVA)
A novel screening program for vascular disease saves one life for every 169 men assessed, according to late-breaking results from the VIVA trial presented today in a Hot Line LBCT Session at ESC Congress and published in the Lancet. The combined screening for abdominal aortic aneurysm, peripheral artery disease, and hypertension gained more living years for lower costs than European cancer screening programs.
European Union, Central Denmark Region, Danish Independent Research Council, Regional Hospital of Viborg

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
Nature Communications
Worm infection reveals cross-talk in the lymph nodes
By studying a worm infection, EPFL scientists have discovered how lymphatic vessels grow within lymph nodes, with major implications for cancer and inflammation.
Leenaards Foundation

Contact: Nik Papageorgiou
n.papageorgiou@epfl.ch
41-216-932-105
Ecole Polytechnique Fédérale de Lausanne

Public Release: 28-Aug-2017
ESC Congress 2017
16-year study suggests air temperature is external trigger for heart attack
A 16-year study in more than 280,000 patients has suggested that air temperature is an external trigger for heart attack. The findings are presented today at ESC Congress.
Swedish Heart and Lung Foundation, Swedish Scientific Research Council, SSF, Knut and Alice Wallenbergs Foundation, ALF, Skane University Hospital

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Study suggests statins associated with lower rates of breast cancer and mortality
A 14 year study in more than one million people has found that women with high cholesterol have significantly lower rates of breast cancer and improved mortality. The research, presented today at ESC Congress, suggests that statins are associated with lower rates of breast cancer and subsequent mortality.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 28-Aug-2017
ESC Congress 2017
Transcatheter aortic valve implantation safe and effective in nonagenarians
Transcatheter aortic valve implantation (TAVI) is safe and effective in nonagenarians, according to research presented at ESC Congress today.1 The observational study found that nonagenarians who underwent TAVI had worse short-term outcomes but similar one-year outcomes as patients younger than 90 years.
Brazilian Society of Interventional Cardiology

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Showing releases 51-75 out of 1396.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>